The Needlestick
Crisis

A 2021 systematic review cites an estimate of about 3 million healthcare workers exposed to bloodborne pathogens through percutaneous injuries worldwide each year. In the United States alone, the Centers for Disease Control and Prevention (CDC) reports approximately 385,000 sharps-related injuries among hospital-based healthcare workers annually.

A historical NIOSH estimate placed5.6 million U.S. healthcare and related workers at risk of occupational bloodborne-pathogen exposure. Current OSHA guidance identifies nurses and other healthcare personnel as workers at risk and emphasizes safer devices as the primary engineering control.

These are not abstract numbers. Each injury represents a healthcare worker — a nurse, a surgeon, a lab technician — who now faces weeks or months of anxiety, prophylactic medication with severe side effects, and the possibility of a life-altering diagnosis.

A single needlestick can transmit over 20 bloodborne pathogens. The three most serious — HIV, Hepatitis B (HBV), and Hepatitis C (HCV) — account for the vast majority of occupationally acquired infections among healthcare workers. The WHO's Global Burden of Disease study quantifies the annual toll:

Needlestick injury incidence varies across the studies represented in global evidence syntheses. A 2022 WHO Eastern Mediterranean Health Journal meta-analysis reported a 43% pooled incidence, with the highest regional estimate in the WHO African Region and the lowest in the Western Pacific Region.

Needlestick injuries affect healthcare workers across roles and settings. The 2022 WHO evidence synthesis identifies the highest reported shares among nurses and physicians, and general wards and operating rooms as the most frequently reported locations.

In the late 1980s, Texas engineer Thomas Shaw developed a retractable safety syringe — a device that automatically retracts the needle into the barrel after use, making accidental needlestick injuries far less likely. The device received federal support and regulatory clearance, while safety-engineered devices became a central prevention strategy.

But for over a decade, Group Purchasing Organizations (GPOs) — intermediaries negotiating hospital-supply contracts — were alleged to have blocked Shaw's VanishPoint syringe from reaching the market. Their exclusive dealing arrangements with Becton Dickinson, the dominant syringe manufacturer, created a system where hospitals that tried to purchase safer devices were threatened with losing their bulk pricing on all other supplies.

The litigation brought the question of whether safer technology was being kept from healthcare workers into public view — a dispute later reflected in the story told by Puncture.

In 1998, Houston attorneys Paul Danziger and Mike Weiss filed a federal antitrust lawsuit on behalf of Retractable Technologies against Becton Dickinson and the GPOs. The case alleged that exclusive dealing arrangements violated antitrust law by blocking safer products from reaching the market — while healthcare workers continued to be injured and infected.

After Mike Weiss's death from a drug overdose on October 2, 1999, Paul Danziger carried the fight alone. The case ultimately settled for $100 million in 2004. The Needlestick Safety and Prevention Act had already become law in 2000 amid a broader national response to occupational sharps injuries and safer-device technology.

This is the true story told in the 2011 film Puncture, starring Chris Evans as Mike Weiss and executive produced by Paul Danziger. Read the full true story →

The fight for safety needles produced landmark legislation in the United States and catalyzed global regulatory action:

Significant progress has been made since the Needlestick Safety and Prevention Act. In the United States, the adoption of safety-engineered devices has reduced needlestick injuries substantially in facilities that fully implemented the technology. However, the crisis is far from over:

• ▸More than 2 million occupational exposures among healthcare workers are still cited annually in global estimates
• ▸Underreporting complicates surveillance, which is why OSHA requires sharps-injury logs and CDC emphasizes incident reporting
• ▸Cost barriers persist in developing nations where conventional syringes remain cheaper than safety devices
• ▸Compliance gaps exist even in the U.S. — not all facilities have fully adopted safety-engineered devices

The evidence summarized above supports sustained investment in safety-engineered devices, training, reporting, and access. Until every healthcare worker can work with appropriate protections, the fight that inspired Puncture remains unfinished.